Fosun Pharma repurchases shares worth HKD 9.98m

** Shanghai Fosun Pharmaceutical Group Co., Ltd. announced that it repurchased 726,500 of its H-shares on the Hong Kong Stock Exchange on May 2, 2025. The shares were bought back at a price range of between HKD 13.56 and HKD 13.82 per share, representing a total cost of HKD 9,975,760. Following this transaction, the number of shares repurchased under the buyback mandate amounts to 10,650,000 shares, accounting for 1.93% of the company's issued shares prior to the granting of the repurchase mandate. The repurchase mandate was approved on June 26, 2024. The company intends to hold these shares as inventory.